HEALTHCARE JOINT VENTURES
Objective Intelligence for Purposeful Healthcare Partnerships
Navigate complex affiliations and joint operating agreements with objective, healthcare-exclusive transaction advisory.
Aligning Transactions with Long-Term Objectives
Entering a joint venture, affiliation, or transaction without clear goal alignment can impact enterprise value. Leaders must identify the right partners and transaction structures, whether they are expanding their footprint or preparing an asset for a strategic exit.
VMG Health delivers comprehensive partnership and M&A advisory to support your executive team as you evaluate joint operating agreements and assess market entry opportunities. By acting as an objective data buffer, our healthcare-exclusive advisors bring third-party validation to the deal table. We equip your leadership with the precise analytical leverage required to evaluate target entities, align distinct operating models, and structure agreements that drive long-term growth.
Definitive Guidance for Complex Affiliations
Navigating high-stakes negotiations requires a partner who looks beyond a simple broker framework to evaluate true financial viability. VMG Health equips your leadership and board with clear, data-driven frameworks.
- Identify strategic partners and execute comprehensive financial due diligence.
- Align your enterprise transactions with your long-term business plan.
- Design alignment models that optimize value for both buyers and sellers.
- Evaluate strategic relationships with total clarity and objective intelligence.
Strategic Solutions for C-Suites & Dealmakers
Partnership Strategy Experts
John Poziemski
Head of Strategy & Partnership Advisory
Chad Zoretic, CEPA
Managing Director & Partnerships, Mergers & Acquisitions Practice Leader
Lukas Recio, CPA
Managing Director
Joe Scott, CPA
Managing Director
Edward J. McGrath
Managing Director
Hear From VMG Health Partnerships, Mergers & Acquisitions Clients
Actionable Intelligence for Strategic Healthcare Decision-Making
Equip your deal team with the exact financial frameworks and strategic intelligence designed by and for healthcare leaders.
PACE Capitation Meets For-Profit Capital
Since 1971, the Program of All-Inclusive Care for the Elderly (PACE) has operated as one of healthcare’s most effective yet least scaled models. Created to keep nursing home–eligible seniors in their own homes, PACE combines full clinical responsibility with full financial risk. Historically, the…
June 25, 2026
Scaling Cardiology: How Site-of-Care Strategy Is Reshaping M&A
Cardiology transaction activity remains strong, but the underlying investment strategy has evolved significantly over the last several years. Historically, many
Read More
June 10, 2026
When Valuation Formulas & Internally Prepared Valuations Become Compliance Risks
In 2025, civil fraud recoveries reached record levels, primarily driven by healthcare–related qui tam lawsuits. As the Department of Justice
Read More
June 9, 2026
The Next Phase of DSO Consolidation: Opportunity Still Exists, but Expectations Have Changed
The dental service organization (DSO) market remains active, but the environment surrounding transactions has become significantly more disciplined than it
Read More
May 21, 2026
Pharmacy M&A in Transition: Key Trends Shaping 2026
The pharmacy services sector saw substantial M&A activity between June 2025 and May 2026, as private equity firms continued to
Read More
March 11, 2026
From Policy to Profit: The Biggest Takeaways from Healthcare’s Q4 2025 Earnings Season
As Q4 2025 earnings season wraps up, VMG Health observed some key themes from the publicly traded payers’ and hospital
Read More
March 10, 2026
Scaling DSOs: Why Integration & Liquidity Planning Matter Now
Dental service organizations are no longer an emerging model: They are a permanent and expanding part of the dental landscape.
Read More
March 9, 2026
Healthcare M&A: 2025 Trends and 2026 Outlook
Drawing on findings from VMG Health’s 2026 Healthcare M&A Report, this webinar will highlight how buyers and operators are adapting
Read More
March 2, 2026
2026 Healthcare M&A Report
Your Annual M&A Strategy Starts Here: VMG Health’s 2026 Healthcare M&A Report The 2025 healthcare M&A market reflected the impact
Read More
February 12, 2026
Why Quality of Revenue Matters More Than EBITDA in DSO Strategy
EBITDA Is Only the Beginning In dental service organizations (DSOs), EBITDA often dominates conversations about growth, performance, and valuation, but
Read MorePartnerships, Mergers & Acquisitions Strategy Frequently Asked Questions
Frequently Asked Questions
How do you assist with joint ventures?
We deliver comprehensive healthcare partnership strategy to support your team as you identify strategic partners and design alignment models that optimize value. Whether you are structuring a hospital joint venture or a physician-led affiliation, our advisors ensure the transaction aligns precisely with your long-term objectives.
Do you help organizations evaluate new markets?
Yes. We provide a thorough and data-backed market entry and exit strategy to help your board and executive team determine the true financial feasibility of expanding your footprint or divesting an underperforming asset.
Can you support the operational details of a transaction?
Absolutely. We move beyond standard financial modeling by providing comprehensive operational and clinical due diligence. Our transaction advisors examine daily workflows, management practices, and clinical protocols to identify exact areas for post-close performance improvement, ensuring your newly integrated enterprise is positioned for long-term success.
Secure the Financial Future of Your Expanded Enterprise
Advance your enterprise growth with targeted partnership and M&A strategy advisory.
Speak to an Expert